Literature DB >> 19608688

Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.

Antonella Vitale, Sara Grammatico, Saveria Capria, Carina Fiocchi, Robin Foà, Giovanna Meloni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19608688      PMCID： PMC2754972          DOI： 10.3324/haematol.2009.011718

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.

Authors:  Marco Vignetti; Paola Fazi; Giuseppe Cimino; Giovanni Martinelli; Francesco Di Raimondo; Felicetto Ferrara; Giovanna Meloni; Achille Ambrosetti; Giovanni Quarta; Livio Pagano; Giovanna Rege-Cambrin; Loredana Elia; Raffaello Bertieri; Luciana Annino; Robin Foà; Michele Baccarani; Franco Mandelli
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

2.  Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Authors:  Antonella Vitale; Anna Guarini; Cristina Ariola; Giovanna Meloni; Omar Perbellini; Michele Pizzuti; Cinzia De Gregoris; Vincenzo Mettivier; Alessandro Pastorini; Giovanni Pizzolo; Marco Vignetti; Franco Mandelli; Robin Foà
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

3.  Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.

Authors:  Sima Jeha; Paul S Gaynon; Bassem I Razzouk; Janet Franklin; Richard Kadota; Violet Shen; Lori Luchtman-Jones; Michael Rytting; Lisa R Bomgaars; Susan Rheingold; Kim Ritchey; Edythe Albano; Robert J Arceci; Stewart Goldman; Timothy Griffin; Arnold Altman; Bruce Gordon; Laurel Steinherz; Steven Weitman; Peter Steinherz
Journal:  J Clin Oncol       Date:  2006-04-20       Impact factor: 44.544

4.  Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

Authors:  Luciana Annino; Maria Luce Vegna; Andrea Camera; Giorgina Specchia; Giuseppe Visani; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Stefania Ciolli; Wilma Deplano; Francesco Fabbiano; Simona Sica; Francesco Di Raimondo; Nicola Cascavilla; Antonio Tabilio; Pietro Leoni; Rosangela Invernizzi; Michele Baccarani; Bruno Rotoli; Sergio Amadori; Franco Mandelli
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib.

Authors:  Simona Soverini; Giovanni Martinelli; Marilina Amabile; Angela Poerio; Michele Bianchini; Gianantonio Rosti; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
Journal:  Clin Chem       Date:  2004-04-23       Impact factor: 8.327

Review 6.  Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges.

Authors:  Deborah A Thomas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

Review 7.  Clofarabine: past, present, and future.

Authors:  Hagop M Kantarjian; Sima Jeha; Varsha Gandhi; Michael Wess; Stefan Faderl
Journal:  Leuk Lymphoma       Date:  2007-10

8.  A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.

Authors:  Judith E Karp; Rebecca M Ricklis; Kumudha Balakrishnan; Janet Briel; Jacqueline Greer; Steven D Gore; B Douglas Smith; Michael A McDevitt; Hetty Carraway; Mark J Levis; Varsha Gandhi
Journal:  Blood       Date:  2007-06-11       Impact factor: 22.113
  8 in total
  2 in total

1.  Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.

Authors:  Amer M Zeidan; Rebecca M Ricklis; Hetty E Carraway; Hyun D Yun; Jacqueline M Greer; B Douglas Smith; Mark J Levis; Michael A McDevitt; Keith W Pratz; Margaret M Showel; Douglas E Gladstone; Steven D Gore; Judith E Karp
Journal:  Br J Haematol       Date:  2012-05-18       Impact factor: 6.998

2.  Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Miriam Frech; Lutz B Jehn; Kathleen Stabla; Stephan Mielke; Björn Steffen; Hermann Einsele; Stephan K Metzelder; Andreas Neubauer
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.